Ubiquitin Regulates Caspase Recruitment Domain-mediated Signaling by Nucleotide-binding Oligomerization Domain-containing Proteins NOD1 and NOD2

被引:37
|
作者
Heul, Aaron M. Ver [1 ,2 ]
Fowler, C. Andrew [3 ]
Ramaswamy, S. [2 ,4 ]
Piper, Robert C. [1 ]
机构
[1] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52246 USA
[2] Univ Iowa, Dept Biochem, Iowa City, IA 52246 USA
[3] Carver Coll Med, NMR Facil, Iowa City, IA 52246 USA
[4] Inst Stem Cell Biol & Regenerat Med, Bangalore 560065, Karnataka, India
基金
美国国家卫生研究院;
关键词
RIG-I; STRUCTURAL BASIS; INNATE; RECOGNITION; ACTIVATION; AUTOPHAGY; RECEPTORS; CARD; IMMUNITY; PEPTIDOGLYCAN;
D O I
10.1074/jbc.M112.413781
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
NOD1 and NOD2 (nucleotide-binding oligomerization domain-containing proteins) are intracellular pattern recognition receptors that activate inflammation and autophagy. These pathways rely on the caspase recruitment domains (CARDs) within the receptors, which serve as protein interaction platforms that coordinately regulate immune signaling. We show that NOD1 CARD binds ubiquitin (Ub), in addition to directly binding its downstream targets receptor-interacting protein kinase 2 (RIP2) and autophagy-related protein 16-1 (ATG16L1). NMR spectroscopy and structure-guided mutagenesis identified a small hydrophobic surface of NOD1 CARD that binds Ub. In vitro, Ub competes with RIP2 for association with NOD1 CARD. In vivo, we found that the ligand-stimulated activity of NOD1 with a mutant CARD lacking Ub binding but retaining ATG16L1 and RIP2 binding is increased relative to wild-type NOD1. Likewise, point mutations in the tandem NOD2 CARDs at positions analogous to the surface residues defining the Ub interface on NOD1 resulted in loss of Ub binding and increased ligand-stimulated NOD2 signaling. These data suggest that Ub binding provides a negative feedback loop upon NOD-dependent activation of RIP2.
引用
收藏
页码:6890 / 6902
页数:13
相关论文
共 50 条
  • [1] Deficiency of Nucleotide-binding oligomerization domain-containing proteins (NOD) 1 and 2 reduces atherosclerosis
    Ann-Kathrin Vlacil
    Jutta Schuett
    Volker Ruppert
    Muhidien Soufi
    Raghav Oberoi
    Kinan Shahin
    Christian Wächter
    Thomas Tschernig
    Yu Lei
    Fan Liu
    Uwe J. F. Tietge
    Bernhard Schieffer
    Harald Schuett
    Karsten Grote
    Basic Research in Cardiology, 2020, 115
  • [2] Deficiency of Nucleotide-binding oligomerization domain-containing proteins (NOD) 1 and 2 reduces atherosclerosis
    Vlacil, Ann-Kathrin
    Schuett, Jutta
    Ruppert, Volker
    Soufi, Muhidien
    Oberoi, Raghav
    Shahin, Kinan
    Waechter, Christian
    Tschernig, Thomas
    Lei, Yu
    Liu, Fan
    Tietge, Uwe J. F.
    Schleifer, Bernhard
    Schuett, Harald
    Grote, Karsten
    BASIC RESEARCH IN CARDIOLOGY, 2020, 115 (04)
  • [3] IMPACT OF THE NUCLEOTIDE-BINDING OLIGOMERIZATION DOMAIN-CONTAINING PROTEINS (NOD) 1 AND 2 ON EXPERIMENTAL ATHEROSCLEROSIS AND LIPID METABOLISM
    Vlacil, A.
    Schuett, H.
    Schuett, J.
    Oberoi, R.
    Tietge, U.
    Schieffer, B.
    Grote, K.
    ATHEROSCLEROSIS, 2018, 275 : E36 - E36
  • [4] Pathogen Sensing by Nucleotide-binding Oligomerization Domain-containing Protein 2 (NOD2) Is Mediated by Direct Binding to Muramyl Dipeptide and ATP
    Mo, Jinyao
    Boyle, Joseph P.
    Howard, Christopher B.
    Monie, Tom P.
    Davis, Beckley K.
    Duncan, Joseph A.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (27) : 23057 - 23067
  • [5] Characterization of Rabbit Nucleotide-Binding Oligomerization Domain 1 (NOD1) and the Role of NOD1 Signaling Pathway during Bacterial Infection
    Guo, Mengjiao
    Wu, Fahao
    Zhang, Zhongfang
    Hao, Guangen
    Li, Rong
    Li, Ning
    Shang, Yingli
    Wei, Liangmeng
    Chai, Tongjie
    FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [6] Altering expressions of NOD1 and NOD2 (nucleotide-binding oligomerization domain) receptors in human clear cell renal cell carcinom
    Urbschat, Anja
    Maier, Thorsten
    Lemming, Debbie
    Boysen, Kristina
    Hofmann, Rainer
    Hegele, Axel
    SCANDINAVIAN JOURNAL OF UROLOGY, 2017, 51 : 50 - 50
  • [7] IMMUNE RECEPTORS NUCLEOTIDE-BINDING OLIGOMERIZATION DOMAIN-CONTAINING PROTEINS (NOD)1 AND 2 ARE REGULATORS OF CHOLESTEROL METABOLISM AND ATHEROGENESIS
    Vlacil, A. K.
    Schuett, H.
    Schuett, J.
    Ruppert, V.
    Soufi, M.
    Oberoi, R.
    Tietge, U.
    Schieffer, B.
    Grote, K.
    ATHEROSCLEROSIS, 2019, 287 : E20 - E20
  • [8] Nucleotide-binding oligomerization domain 1 (NOD1) regulates microglial activation in pseudorabies virus infection
    Sun, Xiuxiu
    Jin, Xinxin
    Lin, Zhengdan
    Liu, Xi
    Yang, Junjie
    Li, Li
    Feng, Helong
    Zhang, Wanpo
    Gu, Changqin
    Hu, Xueying
    Liu, Xiaoli
    Cheng, Guofu
    VETERINARY RESEARCH, 2024, 55 (01)
  • [9] Role of nucleotide-binding oligomerization domain 1 (NOD1) in pericyte-mediated vascular inflammation
    Navarro, Rocio
    Delgado-Wicke, Pablo
    Nunez-Prado, Natalia
    Compte, Marta
    Blanco-Toribio, Ana
    Nunez, Gabriel
    Alvarez-Vallina, Luis
    Sanz, Laura
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2016, 20 (05) : 980 - 986
  • [10] Protection from Influenza A Virus Infection by Modulating Nucleotide-Binding Oligomerization Domain Containing 2 (NOD2) Signaling
    Wiese, Kristin Marie
    Koch, Clarissa M.
    Coates, Bria
    Ridge, Karen M.
    FASEB JOURNAL, 2017, 31